Rating date
Jun 2, 2026
69 days ago
CL Equity Research — HOLD — June 2026
Rating date
Jun 2, 2026
69 days ago
Desk view
HOLD
5D move
-2.49%
Neutral (HOLD unscored)
Peer rank
41p
Research history
2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 moreInvestment card · CL
Here is the analysis for CL (Crude Oil Futures) as of June 2, 2026.
Desk rating
HOLD
Tactical HOLD · 12M HOLD
Horizon
Long-term
Confidence
Medium
Invalidation
Fundamentals show a clear earnings-quality warning: net income collapsed 26% in FY2025, driven by a loss of –$37M in Q4 2025. That is an outlier quarter for a consumer staple, and it underscores how sensitive margins are to cost inflation and demand shifts. Yes, gross margins are healthy at ~60%, but leverage is extreme — debt-to-equity of 1,640% (per the vendor’s calculation) and book value per share of just $0.18 means there is almost no equity cushion. A small misstep in operating performance could magnify downside in the stock.
Bias
HOLD
Catalysts
Risks
Price context alongside the research narrative.
Full desk note for Jun 2, 2026. Use tabs for catalysts, valuation and risks, or open the full note.
WebserviceX · Agentic Research Desk
CL bias
HOLD
Horizon
Long-term
CL key risk
Fundamentals show a clear earnings-quality warning: net income collapsed 26% in FY2025, driven by a loss of –$37M in Q4 2025. That is an outlier quarter for a consumer staple, and it underscores how sensitive margins are to cost inflation and demand shifts. Yes, gross margins are healthy at ~60%, but leverage is extreme — debt-to-equity of 1,640% (per the vendor’s calculation) and book value per share of just $0.18 means there is almost no equity cushion. A small misstep in operating performance could magnify downside in the stock.
CL catalyst watch
Pricing power is the dominant — and nearly only — theme in recent CL-specific coverage, with Zacks questioning whether it is sustainable.
Invalidation
Fundamentals show a clear earnings-quality warning: net income collapsed 26% in FY2025, driven by a loss of –$37M in Q4 2025. That is an outlier quarter for a consumer staple, and it underscores how sensitive margins are to cost inflation and demand shifts. Yes, gross margins are healthy at ~60%, but leverage is extreme — debt-to-equity of 1,640% (per the vendor’s calculation) and book value per share of just $0.18 means there is almost no equity cushion. A small misstep in operating performance could magnify downside in the stock.
Confidence
Medium
How the call aged · 5D
Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-09T07:21:32.509916+00:00.
5D move
-2.49%
2026-06-02 → 2026-06-08
Outcome
Neutral (HOLD unscored)
5D trend
-1.76%
Vol (20D ann.)
+17.30%
vs SPY: -2.95%
Close 88.27 → — (USD, vendor closes)
Publish QC
Pipeline fingerprint 781c0b04aa680fac
No QC issues recorded.